We previously demonstrated that inhibition of Bcl-2/Bcl-xL by ABT-737 alone can induce apoptosis in CD34+ CML BC progenitor cells, and this effect is further enhanced by combining ABT-737 with imatinib [14]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.